Similar articles

• Is there a problem with ezetimibe or just ENHANCEd hype?

  Whayne TF Jr. Whayne TF Jr. Angiology. 2008 Dec-2009 Jan;59(6):661-3. doi: 10.1177/0003319708321188. Epub 2008 Sep 15. Angiology. 2008. PMID: 18796445 No abstract available.
• In brief: Zetia and Vytorin: the ENHANCE study.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2008 Jan 28;50(1278):5. Med Lett Drugs Ther. 2008. PMID: 18219263 No abstract available.
• Cardiovascular primary prevention: how high should we set the bar?

  Prasad V, Vandross A. Prasad V, et al. Arch Intern Med. 2012 Apr 23;172(8):656-9; discussion 659. doi: 10.1001/archinternmed.2012.812. Arch Intern Med. 2012. PMID: 22529231
• Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

  Daskalopoulou SS, Mikhailidis DP. Daskalopoulou SS, et al. Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856. Curr Med Res Opin. 2006. PMID: 16574035 Review.
• Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.

  Gotto AM Jr, Farmer JA. Gotto AM Jr, et al. Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. doi: 10.1038/ncpcardio0711. Nat Clin Pract Cardiovasc Med. 2006. PMID: 17122799 Review.